UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Anti-CD137 monoclonal antibody administration augments the antitumor efficacy of dendritic cell-based vaccines

Cancer research (Chicago, Ill.), 2004-11, Vol.64 (22), p.8411-8419

2004

Volltextzugriff (PDF)

Radiotherapy potentiates the therapeutic efficacy of intratumoral dendritic cell administration

Cancer research (Chicago, Ill.), 2003-12, Vol.63 (23), p.8466-8475

2003

Volltextzugriff (PDF)

Polarization effects of 4-1BB during CD28 costimulation in generating tumor-reactive T cells for cancer immunotherapy

Cancer research (Chicago, Ill.), 2003-05, Vol.63 (10), p.2546-2552

2003

Volltextzugriff (PDF)

A truncated β-catenin disrupts the interaction between E-cadherin and α-catenin: a cause of loss of intercellular adhesiveness in human cancer cell lines

Cancer research (Chicago, Ill.), 1994-12, Vol.54 (23), p.6282-6287

1994

Volltextzugriff (PDF)

The α subunit of GTP-binding protein G0 in neuroblastoma : correlation with advanced disease stage

Cancer research (Chicago, Ill.), 1994-05, Vol.54 (9), p.2334-2336

1994

Volltextzugriff (PDF)

Alteration of hexosaminidase isozymes in human renal carcinoma

Cancer research (Chicago, Ill.), 1979-05, Vol.39 (5), p.1829-1834

1979

Volltextzugriff (PDF)

Intraperitoneal Paclitaxel Is a Safe and Effective Therapeutic Strategy for Treating Mucinous Appendiceal Adenocarcinoma

Cancer research (Chicago, Ill.), 2023-10, Vol.83 (19), p.3184-3191

2023

Volltextzugriff (PDF)

Abstract P1-03-08: Simultaneous analyses of HER2 gene and protein status can more precisely predict pathological complete response (pCR) to neoadjuvant trastuzumab with chemotherapy in primary HER2-positive breast cancer

Cancer research (Chicago, Ill.), 2017-02, Vol.77 (4_Supplement), p.P1-P1-03-08

2017

Volltextzugriff (PDF)

Abstract P4-08-29: Lymphatic invasion is an independent risk factor in patients with small node-negative luminal breast cancer

Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4_Supplement), p.P4-P4-08-29

2019

Volltextzugriff (PDF)

Abstract 6546: Peritoneal microenvironment promotes appendiceal adenocarcinoma tumor formation in PDX models

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (7_Supplement), p.6546-6546

2023

Volltextzugriff (PDF)

Abstract CT221: CHRONOS-3: A phase III, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of phosphatidylinositol-3 kinase (PI3K) alpha/delta inhibitor copanlisib in combination with rituximab in patients with relapsed indolent B-c

Cancer research (Chicago, Ill.), 2015-08, Vol.75 (15_Supplement), p.CT221-CT221

2015

Volltextzugriff (PDF)

Abstract 6040: Orthotopic patient-derived xenograft models of appendiceal adenocarcinoma identify intraperitoneal paclitaxel treatment as an active therapeutic agent

Cancer research (Chicago, Ill.), 2022-06, Vol.82 (12_Supplement), p.6040-6040

2022

Volltextzugriff (PDF)

Abstract P4-02-13: The pattern of tumor shrinkage is associated with prognosis in low grade luminal early breast cancer during neoadjuvant chemotherapy

Cancer research (Chicago, Ill.), 2016-02, Vol.76 (4_Supplement), p.P4-P4-02-13

2016

Volltextzugriff (PDF)

Abstract 4082: CD47 blockade to enhance adaptive anti-tumor immune responses

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19_Supplement), p.4082-4082

2014

Volltextzugriff (PDF)

Abstract CT085: Phase III randomized, double-blind, controlled studies of the PI3K inhibitor copanlisib in combination with rituximab or rituximab-based chemotherapy in subjects with relapsed indolent B-cell non-Hodgkin's lymphoma (iNHL): CHRONOS-3 and CHRONOS-4

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.CT085-CT085

2016

Volltextzugriff (PDF)

Abstract 3482: Validation of novel therapeutic targets for T-cell non-Hodgkin lymphoma

Cancer research (Chicago, Ill.), 2012-04, Vol.72 (8_Supplement), p.3482-3482

2012

Volltextzugriff (PDF)

Genetic blockade of the insulin-like growth factor-I receptor: A promising strategy for human pancreatic cancer

Cancer research (Chicago, Ill.), 2003-10, Vol.63 (19), p.6432-6441

2003

Volltextzugriff (PDF)

Memory Type 2 Helper T Cells Induce Long-Lasting Antitumor Immunity by Activating Natural Killer Cells

Cancer research (Chicago, Ill.), 2011-07, Vol.71 (14), p.4790-4798

2011

Volltextzugriff (PDF)

Down-regulation of CD9 in Human Ovarian Carcinoma Cell Might Contribute to Peritoneal Dissemination: Morphologic Alteration and Reduced Expression of beta 1 Integrin Subsets

Cancer research (Chicago, Ill.), 2005-04, Vol.65 (7), p.2617-2625

2005

Volltextzugriff (PDF)

Abstract 1272: Myeloid leukemia cell lines suppress T cell activation and proliferation

Cancer research (Chicago, Ill.), 2013-04, Vol.73 (8_Supplement), p.1272-1272

2013

Volltextzugriff (PDF)

P1-02-09: Epigenetics-Regulated microRNAs Related with Epithelial-Mesenchymal Transition of Breast Cancer Cells

Cancer research (Chicago, Ill.), 2011-12, Vol.71 (24_Supplement), p.P1-P1-02-09

2011

Volltextzugriff (PDF)

Abstract P1-11-13: Triple Negative or HER2 Positive Subtypes of Breast Cancer Groups Are Chemo-Sensitive, but Higher Rate of Brain Metastasis Contributes Poorer Prognosis

Cancer research (Chicago, Ill.), 2010-12, Vol.70 (24_Supplement), p.P1-P1-11-13

2010

Volltextzugriff (PDF)

Abstract P3-03-02: Molecular Detection of Micrometastasis in Sentinel Lymph Nodes Using One-Step Nucleic Acid Amplification Assay for Breast Cancer Patients — Comparison with Routine Pathological Examination

Cancer research (Chicago, Ill.), 2010-12, Vol.70 (24_Supplement), p.P3-P3-03-02

2010

Volltextzugriff (PDF)

Abstract 5377: Low donor thymic output predicts increased incidence of extensive chronic GVHD and worse overall survival after TCD-matched sibling SCT

Cancer research (Chicago, Ill.), 2012-04, Vol.72 (8_Supplement), p.5377-5377

2012

Volltextzugriff (PDF)

Abstract 4307: Characterization of a novel lymphoid progenitor population with predictive value in canine non-Hodgkin lymphoma

Cancer research (Chicago, Ill.), 2010-04, Vol.70 (8_Supplement), p.4307-4307

2010

Volltextzugriff (PDF)

1 – 25 von 42

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieCancer Research

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(42)
Mit Volltextzugriff
(41)

Publikationsform

Artikel
(42)

Sprache

Englisch
(42)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Zeitschrift / Serie

Cancer Res
(1)

Menü

Weitere Dienste

Einstellungen

Anti-CD137 monoclonal antibody administration augments the antitumor efficacy of dendritic cell-based vaccines

Radiotherapy potentiates the therapeutic efficacy of intratumoral dendritic cell administration

Polarization effects of 4-1BB during CD28 costimulation in generating tumor-reactive T cells for cancer immunotherapy

A truncated β-catenin disrupts the interaction between E-cadherin and α-catenin: a cause of loss of intercellular adhesiveness in human cancer cell lines

The α subunit of GTP-binding protein G0 in neuroblastoma : correlation with advanced disease stage

Alteration of hexosaminidase isozymes in human renal carcinoma

Intraperitoneal Paclitaxel Is a Safe and Effective Therapeutic Strategy for Treating Mucinous Appendiceal Adenocarcinoma

Abstract P1-03-08: Simultaneous analyses of HER2 gene and protein status can more precisely predict pathological complete response (pCR) to neoadjuvant trastuzumab with chemotherapy in primary HER2-positive breast cancer

Abstract P4-08-29: Lymphatic invasion is an independent risk factor in patients with small node-negative luminal breast cancer

Abstract 6546: Peritoneal microenvironment promotes appendiceal adenocarcinoma tumor formation in PDX models

Abstract CT221: CHRONOS-3: A phase III, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of phosphatidylinositol-3 kinase (PI3K) alpha/delta inhibitor copanlisib in combination with rituximab in patients with relapsed indolent B-c

Abstract 6040: Orthotopic patient-derived xenograft models of appendiceal adenocarcinoma identify intraperitoneal paclitaxel treatment as an active therapeutic agent

Abstract P4-02-13: The pattern of tumor shrinkage is associated with prognosis in low grade luminal early breast cancer during neoadjuvant chemotherapy

Abstract 4082: CD47 blockade to enhance adaptive anti-tumor immune responses

Abstract CT085: Phase III randomized, double-blind, controlled studies of the PI3K inhibitor copanlisib in combination with rituximab or rituximab-based chemotherapy in subjects with relapsed indolent B-cell non-Hodgkin's lymphoma (iNHL): CHRONOS-3 and CHRONOS-4

Abstract 3482: Validation of novel therapeutic targets for T-cell non-Hodgkin lymphoma

Genetic blockade of the insulin-like growth factor-I receptor: A promising strategy for human pancreatic cancer

Memory Type 2 Helper T Cells Induce Long-Lasting Antitumor Immunity by Activating Natural Killer Cells

Down-regulation of CD9 in Human Ovarian Carcinoma Cell Might Contribute to Peritoneal Dissemination: Morphologic Alteration and Reduced Expression of beta 1 Integrin Subsets

Abstract 1272: Myeloid leukemia cell lines suppress T cell activation and proliferation

P1-02-09: Epigenetics-Regulated microRNAs Related with Epithelial-Mesenchymal Transition of Breast Cancer Cells

Abstract P1-11-13: Triple Negative or HER2 Positive Subtypes of Breast Cancer Groups Are Chemo-Sensitive, but Higher Rate of Brain Metastasis Contributes Poorer Prognosis

Abstract P3-03-02: Molecular Detection of Micrometastasis in Sentinel Lymph Nodes Using One-Step Nucleic Acid Amplification Assay for Breast Cancer Patients — Comparison with Routine Pathological Examination

Abstract 5377: Low donor thymic output predicts increased incidence of extensive chronic GVHD and worse overall survival after TCD-matched sibling SCT

Abstract 4307: Characterization of a novel lymphoid progenitor population with predictive value in canine non-Hodgkin lymphoma

Aktive Filter

Suchergebnisse filtern